CARTERVILLE, Ill. (KFVS) - In Williamson County, Southern Illinois Healthcare is expanding access to advanced cancer clinical trials, including a global study rarely offered outside major metropolitan ...
Stony Brook Medicine opened its 6,000-square-foot Clinical Trials Unit at the Advanced Specialty Care at Commack center. Celebrated with a ribbon-cutting on Monday, the unit provides patients with a ...
MedCity News: Augmenting Brain Power: Real-World Data, Advanced Analytics, and the Future of Clinical Trials
Augmenting Brain Power: Real-World Data, Advanced Analytics, and the Future of Clinical Trials
KFVS12: SIH brings global research to southern Illinois with advanced cancer clinical trials
SIH brings global research to southern Illinois with advanced cancer clinical trials
The Business Journals: How precision medicine and clinical trials helped a father’s fight against advanced stage IV melanoma
How precision medicine and clinical trials helped a father’s fight against advanced stage IV melanoma
The mission of the WHO International Clinical Trials Registry Platform is to ensure that a complete view of research is accessible to all those involved in health care decision making. This will improve research transparency and will ultimately strengthen the validity and value of the scientific evidence base.
Yahoo Finance: Forlong Biotechnology to Present Clinical Data from the First-in-human Study for FL115 (IL-15 Superagonist) in US Patients with Advanced Solid Tumors at 2026 ASCO Annual Meeting
Forlong Biotechnology to Present Clinical Data from the First-in-human Study for FL115 (IL-15 Superagonist) in US Patients with Advanced Solid Tumors at 2026 ASCO Annual Meeting
Medical Xpress: New antibody-drug conjugate shows clinical benefit for advanced platinum-resistant ovarian cancer
Patients with advanced platinum-resistant ovarian cancer whose disease had progressed on standard therapy experienced clinical benefit when treated with the investigational antibody-drug conjugate ...
Seeking Alpha: Silexion Therapeutics Announces Submission of Phase 2/3 Clinical Trial Application to Israel for SIL204 in Locally Advanced Pancreatic Cancer
Silexion Therapeutics Announces Submission of Phase 2/3 Clinical Trial Application to Israel for SIL204 in Locally Advanced Pancreatic Cancer
Yahoo Finance: Obsidian Therapeutics to Present OBX-115 Phase 2 Clinical Data in Advanced Melanoma in Oral Presentation at 2026 ASCO Annual Meeting
Obsidian Therapeutics to Present OBX-115 Phase 2 Clinical Data in Advanced Melanoma in Oral Presentation at 2026 ASCO Annual Meeting
Long Island Business News: Stony Brook Medicine launches clinical trials unit in Commack
In this segment, Dr. Morrison discusses the clinical evidence supporting subcutaneous immunotherapy and explains the concept of noninferiority in the context of advanced melanoma ...
Morningstar: Florida Cancer Specialists & Research Institute Phase 3 Trial Demonstrates Initial Clinical Benefit of Novel Immunotherapy For Advanced Non-Small Cell Lung Cancer
Florida Cancer Specialists & Research Institute Phase 3 Trial Demonstrates Initial Clinical Benefit of Novel Immunotherapy For Advanced Non-Small Cell Lung Cancer
Springfield News-Leader: IDDI Strengthens Position as Contract Research Organization with Advanced Clinical Trial Design Solutions
IDDI Strengthens Position as Contract Research Organization with Advanced Clinical Trial Design Solutions
There are two types of clinical studies: interventional studies (also called clinical trials) and observational studies. The unique identification code given to each clinical study upon registration at ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419).
Clinical trials are a type of research that studies new tests and treatments and evaluates their effects on human health outcomes.
Join WHO for the launch of the free, online, self-paced ‘WHO Good Practices for Clinical Trial Design and Implementation’ course and #StandWithScience in 2026.The course is designed for learners with little or no hands-on experience in conducting clinical trials, though a basic theoretical understanding of standard trial designs and key research concepts is assumed.
Some of the world’s largest funders of medical research have today committed, through the signature of a joint statement, to implement WHO standards to strengthen clinical trial systems and ensure that research better serves patients and communities. The statement sets out measures to integrate clinical trials into sustainable national infrastructure, improve trial design, ensure that trial ...
This guidance updates and adapts the previous work of the World Health Organization (WHO) on research capacity for the context of well-designed and well-implemented clinical trials as framed in resolution WHA75.8 (2022). It aims to enhance clinical research efficiency, minimize research waste and provide guidance on sustained clinical trials that are always functional and active for endemic ...
In September 2024, the World Health Organization (WHO) launched its landmark publication "Guidance for best practices for clinical trials". This pivotal document is described as "not an endpoint but a starting point" (1) for enhancing global health through robust, ethical, and inclusive clinical research. It serves as a foundational resource aimed at improving the design, conduct, and ...
A starting point, not an endpoint: WHO's new clinical trials guidance ...
WHO has today launched the Global Clinical Trials Forum (GCTF), a global, multi-stakeholder network to strengthen clinical trial environments and infrastructure at national, regional and global levels.
Nasdaq: SERENA-6 Phase III Trial Demonstrates Clinical Value of Guardant360 CDx Test to Detect Emergence of Endocrine Resistance and Inform a Switch in Therapy Before Radiological ...
SERENA-6 Phase III Trial Demonstrates Clinical Value of Guardant360 CDx Test to Detect Emergence of Endocrine Resistance and Inform a Switch in Therapy Before Radiological ...
Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients with severe unmet needs, today announced a poster presentation at the ...
Markets Insider: SAB BIO Presents Additional Clinical and Mechanistic Data from SAB-142 Phase 1 Trial in Adult Patients with Established Autoimmune Type 1 Diabetes at IDS 2026
SAB BIO Presents Additional Clinical and Mechanistic Data from SAB-142 Phase 1 Trial in Adult Patients with Established Autoimmune Type 1 Diabetes at IDS 2026
Markets Insider: Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
MarketWatch: Verismo Therapeutics Presents Preclinical Data at AACR 2026 for SynKIR(TM)-310 KIR-CAR Indicating Superior Preclinical Activity in B Cell Malignancies and Early Clinical Efficacy
Preclinical data showed enhanced anti-tumor activity and reduced cytokine release compared to conventional single-chain CAR T approaches -- Early clinical case from CELESTIAL-301 trial, the ...